Annual Working Capital
$408.97 M
-$144.61 M-26.12%
December 28, 2024
Summary
- As of February 26, 2025, CRL annual working capital is $408.97 million, with the most recent change of -$144.61 million (-26.12%) on December 28, 2024.
- During the last 3 years, CRL annual working capital has risen by +$168.06 million (+69.76%).
- CRL annual working capital is now -26.12% below its all-time high of $553.58 million, reached on December 30, 2023.
Performance
CRL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$408.97 M
-$73.53 M-15.24%
December 28, 2024
Summary
- As of February 26, 2025, CRL quarterly working capital is $408.97 million, with the most recent change of -$73.53 million (-15.24%) on December 28, 2024.
- Over the past year, CRL quarterly working capital has dropped by -$142.78 million (-25.88%).
- CRL quarterly working capital is now -42.67% below its all-time high of $713.38 million, reached on March 30, 2024.
Performance
CRL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CRL Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -26.1% | -25.9% |
3 y3 years | +69.8% | -25.9% |
5 y5 years | +31.4% | -25.9% |
CRL Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -26.1% | +69.8% | -42.7% | +69.8% |
5 y | 5-year | -26.1% | +69.8% | -42.7% | +69.8% |
alltime | all time | -26.1% | +1327.4% | -42.7% | +1368.3% |
Charles River Laboratories International Working Capital History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $408.97 M(-26.1%) | $408.97 M(-15.2%) |
Sep 2024 | - | $482.50 M(-12.6%) |
Jun 2024 | - | $551.75 M(-22.7%) |
Mar 2024 | - | $713.38 M(+28.9%) |
Dec 2023 | $553.58 M(+59.3%) | $553.58 M(+22.9%) |
Sep 2023 | - | $450.51 M(-9.4%) |
Jun 2023 | - | $497.16 M(+6.5%) |
Mar 2023 | - | $466.96 M(+34.4%) |
Dec 2022 | $347.45 M(+44.2%) | $347.45 M(-13.4%) |
Sep 2022 | - | $401.16 M(+16.3%) |
Jun 2022 | - | $344.95 M(+1.7%) |
Mar 2022 | - | $339.25 M(+40.8%) |
Dec 2021 | $240.91 M(-33.3%) | $240.91 M(-39.1%) |
Sep 2021 | - | $395.29 M(+16.8%) |
Jun 2021 | - | $338.30 M(-45.4%) |
Mar 2021 | - | $619.83 M(+71.5%) |
Dec 2020 | $361.38 M(+16.1%) | $361.38 M(+2.3%) |
Sep 2020 | - | $353.26 M(-30.3%) |
Jun 2020 | - | $506.79 M(-2.0%) |
Mar 2020 | - | $517.38 M(+66.3%) |
Dec 2019 | $311.14 M(-8.4%) | $311.14 M(+7.0%) |
Sep 2019 | - | $290.76 M(-22.4%) |
Jun 2019 | - | $374.46 M(+11.3%) |
Mar 2019 | - | $336.42 M(-0.9%) |
Dec 2018 | $339.61 M(-6.5%) | $339.61 M(+13.7%) |
Sep 2018 | - | $298.57 M(-19.6%) |
Jun 2018 | - | $371.39 M(-14.9%) |
Mar 2018 | - | $436.25 M(+20.1%) |
Dec 2017 | $363.12 M(+59.8%) | $363.12 M(-1.0%) |
Sep 2017 | - | $366.62 M(+16.8%) |
Jun 2017 | - | $314.00 M(-0.9%) |
Mar 2017 | - | $316.75 M(+39.4%) |
Dec 2016 | $227.24 M(-8.2%) | $227.24 M(-6.3%) |
Sep 2016 | - | $242.53 M(-15.8%) |
Jun 2016 | - | $288.15 M(-12.0%) |
Mar 2016 | - | $327.40 M(+32.3%) |
Dec 2015 | $247.47 M(-13.0%) | $247.47 M(-6.5%) |
Sep 2015 | - | $264.56 M(-25.1%) |
Jun 2015 | - | $353.12 M(+2.8%) |
Mar 2015 | - | $343.65 M(+20.8%) |
Dec 2014 | $284.57 M(-6.9%) | $284.57 M(-11.9%) |
Sep 2014 | - | $322.94 M(+0.6%) |
Jun 2014 | - | $321.05 M(-8.6%) |
Mar 2014 | - | $351.34 M(+15.0%) |
Dec 2013 | $305.52 M(+113.6%) | $305.52 M(-2.3%) |
Sep 2013 | - | $312.61 M(+6.4%) |
Jun 2013 | - | $293.90 M(+81.6%) |
Mar 2013 | - | $161.81 M(+13.1%) |
Dec 2012 | $143.00 M | $143.00 M(+7.8%) |
Sep 2012 | - | $132.68 M(+7.5%) |
Jun 2012 | - | $123.43 M(-42.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $213.44 M(+2.1%) |
Dec 2011 | $209.05 M(-28.7%) | $209.05 M(-10.1%) |
Sep 2011 | - | $232.49 M(-14.3%) |
Jun 2011 | - | $271.15 M(+7.3%) |
Mar 2011 | - | $252.78 M(-13.8%) |
Dec 2010 | $293.11 M(-15.2%) | $293.11 M(+1.1%) |
Sep 2010 | - | $289.92 M(-19.9%) |
Jun 2010 | - | $361.99 M(-1.2%) |
Mar 2010 | - | $366.52 M(+6.0%) |
Dec 2009 | $345.83 M(+9.0%) | $345.83 M(+10.7%) |
Sep 2009 | - | $312.26 M(+4.1%) |
Jun 2009 | - | $300.06 M(-0.6%) |
Mar 2009 | - | $301.85 M(-4.8%) |
Dec 2008 | $317.14 M(+3.9%) | $317.14 M(+198.3%) |
Sep 2008 | - | $106.31 M(-39.7%) |
Jun 2008 | - | $176.16 M(-48.7%) |
Mar 2008 | - | $343.25 M(+12.4%) |
Dec 2007 | $305.34 M(+26.3%) | $305.34 M(+15.2%) |
Sep 2007 | - | $264.98 M(+2.8%) |
Jun 2007 | - | $257.87 M(+9.3%) |
Mar 2007 | - | $235.95 M(-2.4%) |
Dec 2006 | $241.76 M(+124.0%) | $241.76 M(-21.0%) |
Sep 2006 | - | $306.15 M(+21.8%) |
Jun 2006 | - | $251.26 M(+73.7%) |
Mar 2006 | - | $144.64 M(+34.0%) |
Dec 2005 | $107.91 M(-33.1%) | $107.91 M(-40.2%) |
Sep 2005 | - | $180.52 M(+10.7%) |
Jun 2005 | - | $163.06 M(-17.3%) |
Mar 2005 | - | $197.23 M(+22.4%) |
Dec 2004 | $161.19 M(-37.2%) | $161.19 M(-51.0%) |
Sep 2004 | - | $329.29 M(+8.9%) |
Jun 2004 | - | $302.25 M(+9.6%) |
Mar 2004 | - | $275.65 M(+7.5%) |
Dec 2003 | $256.54 M(+55.7%) | $256.54 M(+8.9%) |
Sep 2003 | - | $235.53 M(+11.2%) |
Jun 2003 | - | $211.80 M(+16.0%) |
Mar 2003 | - | $182.53 M(+10.8%) |
Dec 2002 | $164.72 M(+47.6%) | $164.72 M(-4.8%) |
Sep 2002 | - | $173.02 M(+26.0%) |
Jun 2002 | - | $137.33 M(-32.8%) |
Mar 2002 | - | $204.44 M(+83.2%) |
Dec 2001 | $111.62 M(+101.4%) | $111.62 M(-19.1%) |
Sep 2001 | - | $137.96 M(+69.9%) |
Jun 2001 | - | $81.19 M(-15.3%) |
Mar 2001 | - | $95.90 M(+73.1%) |
Dec 2000 | $55.42 M(+93.4%) | $55.42 M(+3.2%) |
Sep 2000 | - | $53.72 M(+30.2%) |
Jun 2000 | - | $41.26 M(+48.1%) |
Mar 2000 | - | $27.85 M |
Dec 1999 | $28.65 M(-17.7%) | - |
Dec 1998 | $34.83 M | - |
FAQ
- What is Charles River Laboratories International annual working capital?
- What is the all time high annual working capital for Charles River Laboratories International?
- What is Charles River Laboratories International annual working capital year-on-year change?
- What is Charles River Laboratories International quarterly working capital?
- What is the all time high quarterly working capital for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly working capital year-on-year change?
What is Charles River Laboratories International annual working capital?
The current annual working capital of CRL is $408.97 M
What is the all time high annual working capital for Charles River Laboratories International?
Charles River Laboratories International all-time high annual working capital is $553.58 M
What is Charles River Laboratories International annual working capital year-on-year change?
Over the past year, CRL annual working capital has changed by -$144.61 M (-26.12%)
What is Charles River Laboratories International quarterly working capital?
The current quarterly working capital of CRL is $408.97 M
What is the all time high quarterly working capital for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly working capital is $713.38 M
What is Charles River Laboratories International quarterly working capital year-on-year change?
Over the past year, CRL quarterly working capital has changed by -$142.78 M (-25.88%)